Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Quadrivalent HPV Vaccine”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT00517309
What this trial is testing

Study to Test the Safety of HPV Vaccine in Women (V501-011)(COMPLETED)

Who this might be right for
Cervical CancerGenital Warts
Merck Sharp & Dohme LLC 1,877
Large-scale testing (Phase 3)Study completedNCT00834106
What this trial is testing

Prevention of Human Papillomavirus (HPV) in 20 to 45 Year Old Chinese Women (V501-041)

Who this might be right for
HPV Infections
Merck Sharp & Dohme LLC 3,006
Not applicableStudy completedNCT02558803
What this trial is testing

HPV Vaccination: Evaluation of Reminder Prompts for Doses 2 & 3

Who this might be right for
Human Papilloma Virus Infection Type 11Human Papilloma Virus Infection Type 16Human Papilloma Virus Infection Type 18+4 more
Regenstrief Institute, Inc. 1,305
Not applicableStudy completedNCT00573651
What this trial is testing

Safety and Efficacy of Gardasil in Females With Juvenile Idiopathic Arthritis (JIA)/Seronegative Arthritis

Who this might be right for
Arthritis
University Hospitals Cleveland Medical Center 43
Testing effectiveness (Phase 2)Study completedNCT00604175
What this trial is testing

Safety of and Immune Response to the Human Papillomavirus (HPV) Vaccine in HIV-Infected Women

Who this might be right for
HIV InfectionsSexually Transmitted Diseases
National Institute of Allergy and Infectious Diseases (NIAID) 319
Large-scale testing (Phase 3)Study completedNCT02576054
What this trial is testing

Safety and Tolerability Study of V501 in Japanese Boys (V501-200)

Who this might be right for
Anogenital Human Papilloma Virus InfectionCondyloma Acuminata
Merck Sharp & Dohme LLC 101
Not applicableStudy completedNCT01206556
What this trial is testing

IMPAACT P1085: Human Papilloma Virus (HPV) Type-Specific Antibody

Who this might be right for
Papilloma Virus, Human
International Maternal Pediatric Adolescent AIDS Clinical Trials Group 97
Not applicableUnknownNCT04022148
What this trial is testing

The Prospective Cohort Study to Evaluate the Preventive Efficacy of HPV Vaccine in Japanese Women Aged 27-45 Years

Who this might be right for
Cancer of CervixVaccinia
University of Fukui 2,800
Large-scale testing (Phase 3)Study completedNCT05383625
What this trial is testing

Gardasil Versus Cervarix in the Treatment of Warts

Who this might be right for
Verruca Viral
Zagazig University 50
Testing effectiveness (Phase 2)Study completedNCT01209325
What this trial is testing

Vaccine Therapy in Preventing Human Papillomavirus Infection in Young HIV-Positive Male Patients Who Have Sex With Males

Who this might be right for
Anal CancerNonneoplastic ConditionPenile Cancer+1 more
AIDS Malignancy Consortium 149
Large-scale testing (Phase 3)Study completedNCT00092521
What this trial is testing

Cervical Intraepithelial Neoplasm (CIN)-Warts Efficacy Trial in Women (Gardasil)(V501-013)(COMPLETED)

Who this might be right for
Cervical CancerGenital Warts
Merck Sharp & Dohme LLC 5,759
Post-approval studies (Phase 4)Study completedNCT01424644
What this trial is testing

A Phase 4, Placebo-Controlled, Randomized Study to Evaluate the Immunogenicity and Safety of HPV and Tdap When Administered With MenACWY in Adolescents

Who this might be right for
Meningococcal Meningitis
Novartis 801
Large-scale testing (Phase 3)Study completedNCT03728881
What this trial is testing

Single Dose of Cervarix Vaccine in Girls or Three Doses of Gardasil Vaccine in Women for the Prevention of Human Papillomavirus Infection, the PRIMAVERA-ESCUDDO Trial

Who this might be right for
Human Papillomavirus-Related Cervical Carcinoma
National Cancer Institute (NCI) 1,240
Testing effectiveness (Phase 2)Study completedNCT00339040
What this trial is testing

Safety of and Immune Response to a Novel Human Papillomavirus Vaccine in HIV Infected Children

Who this might be right for
HIV InfectionsSexually Transmitted Diseases
National Institute of Allergy and Infectious Diseases (NIAID) 130
Large-scale testing (Phase 3)Study completedNCT00677677
What this trial is testing

Safety and Immunogenicity of Human Papillomavirus (HPV) Vaccine in Solid Organ Transplant Recipients

Who this might be right for
Transplant
University of Alberta 50
Post-approval studies (Phase 4)Study completedNCT05435209
What this trial is testing

Effectiveness of the Q-HPV Vaccine 9-years Post Vaccination Among HIV Positive Adolescents

Who this might be right for
HPV InfectionHPV Vaccination
University of Washington 158
Large-scale testing (Phase 3)UnknownNCT02382900
What this trial is testing

Two-dose Schedule of Quadrivalent HPV Recombinant Vaccine in 11-year-old Boys in Mexico City

Who this might be right for
Human Papilloma Virus
Universidad Nacional Autonoma de Mexico 500
Large-scale testing (Phase 3)UnknownNCT03296397
What this trial is testing

Efficacy of Quadrivalent HPV Vaccine to Prevent Relapses of Genital Warts After Initial Therapeutic Response

Who this might be right for
Genital Warts
Assistance Publique - Hôpitaux de Paris 300
Testing effectiveness (Phase 2)Study completedNCT01928225
What this trial is testing

Randomized, Double Blind Trial of the Quadrivalent HPV Vaccine to Improve Responses to LEEP Treatment of Cervical HSIL

Who this might be right for
Cervical High Grade Squamous Intraepithelial Lesion
University of Witwatersrand, South Africa 180
Large-scale testing (Phase 3)Study completedNCT00423046
What this trial is testing

Immunogenicity of GlaxoSmithKline Biological's Human Papillomavirus (HPV) Vaccine (580299) Versus Merck's Gardasil® in Healthy Females 18-45 Years of Age

Who this might be right for
Infections, PapillomavirusPapillomavirus Vaccines
GlaxoSmithKline 1,106
Next Page